Synonyms: Pasil® | Pazucross® | T-3761
pazufloxacin is an approved drug (Japan)
Compound class:
Synthetic organic
Comment: Pazufloxacin is an orally bioavailable fluoroquinolone compound with broad-spectrum antibacterial activity [1-2]. The drug is administered clinically as the mesylate salt (PubChem CID 6918232, T-3762).
|
|
Classification ![]() |
|
Compound class | Synthetic organic |
Approved drug? | Yes. Japan (0) |
International Nonproprietary Names ![]() |
|
INN number | INN |
7247 | pazufloxacin |
Synonyms ![]() |
Pasil® | Pazucross® | T-3761 |
Database Links ![]() |
|
Specialist databases | |
Antibiotic DB
![]() |
Pazufloxacin |
Other databases | |
CAS Registry No. | 127045-41-4 (source: Scifinder) |
ChEBI | CHEBI:94700 |
ChEMBL Ligand | CHEMBL240163 |
DrugBank Ligand | DB11774 |
DrugCentral Ligand | 2070 |
GtoPdb PubChem SID | 479821201 |
PubChem CID | 65957 |
Search Google for chemical match using the InChIKey | XAGMUUZPGZWTRP-ZETCQYMHSA-N |
Search Google for chemicals with the same backbone | XAGMUUZPGZWTRP |
Search PubMed clinical trials | pazufloxacin |
Search PubMed titles | pazufloxacin |
Search PubMed titles/abstracts | pazufloxacin |
UniChem Compound Search for chemical match using the InChIKey | XAGMUUZPGZWTRP-ZETCQYMHSA-N |
UniChem Connectivity Search for chemical match using the InChIKey | XAGMUUZPGZWTRP-ZETCQYMHSA-N |